- Home
- XENE vs HTH Comparison
XENE vs HTH Comparison
Compare XENE & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- HTH
- Stock Information
- Founded
- XENE 1996
- HTH 1998
- Country
- XENE Canada
- HTH United States
- Employees
- XENE N/A
- HTH N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- HTH Major Banks
- Sector
- XENE Health Care
- HTH Finance
- Exchange
- XENE Nasdaq
- HTH Nasdaq
- Market Cap
- XENE 2.4B
- HTH 1.9B
- IPO Year
- XENE 2014
- HTH 2004
- Fundamental
- Price
- XENE $31.75
- HTH $30.32
- Analyst Decision
- XENE Strong Buy
- HTH Hold
- Analyst Count
- XENE 11
- HTH 2
- Target Price
- XENE $54.82
- HTH $33.00
- AVG Volume (30 Days)
- XENE 1.4M
- HTH 406.7K
- Earning Date
- XENE 08-07-2025
- HTH 07-24-2025
- Dividend Yield
- XENE N/A
- HTH 2.36%
- EPS Growth
- XENE N/A
- HTH 15.07
- EPS
- XENE N/A
- HTH 1.97
- Revenue
- XENE $7,500,000.00
- HTH $1,208,822,000.00
- Revenue This Year
- XENE N/A
- HTH N/A
- Revenue Next Year
- XENE $253.71
- HTH $1.36
- P/E Ratio
- XENE N/A
- HTH $15.50
- Revenue Growth
- XENE N/A
- HTH 2.13
- 52 Week Low
- XENE $26.74
- HTH $26.67
- 52 Week High
- XENE $46.00
- HTH $35.32
- Technical
- Relative Strength Index (RSI)
- XENE 52.34
- HTH 57.59
- Support Level
- XENE $31.11
- HTH $29.82
- Resistance Level
- XENE $32.87
- HTH $30.54
- Average True Range (ATR)
- XENE 1.23
- HTH 0.55
- MACD
- XENE 0.16
- HTH 0.05
- Stochastic Oscillator
- XENE 53.76
- HTH 75.12
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.